JusticeItaly Official institution
Italy revokes marketing approval for medicine Kleder at maker's request
Italy's medicines agency AIFA published a notice on 7 November 2026 saying the marketing permission for the human medicine Kleder is being revoked at the request of its license holder. In plain terms, the license holder voluntarily gave up the right to sell the drug in Italy. The notice carries the reference number 26A05797.
This summary was generated by AI; the official source prevails.
What does it mean?
Kleder can no longer be legally sold in Italy under its current approval. The company that held that approval asked to give it up, so the medicine is being taken off the Italian market.
Who is affected?
Patients who use Kleder in Italy and pharmacies that stock it.
What changes?
Before, Kleder was authorized for sale in Italy; now its marketing authorization is being revoked.